Spontaneous Pneumothorax in Adolescents (PNSA)

Spontaneous Pneumothorax in Adolescents: Inventory and Management

Pneumothorax is characterized by an abnormal presence of air in the pleural cavity, that is to say between the two layers of the pleura, the membrane that surrounds the lungs and lines the rib cage. "The patient is usually seized with sudden chest pain and difficulty in breathing.

In this retrospective research, the investigators wish to carry out an inventory of the management of spontaneous pneumothorax in adolescents within the University Hospitals of Strasbourg

Study Overview

• Status: Recruiting
• Conditions: Pneumothorax, Spontaneous

• Study Type: Observational
• Enrollment (Estimated): 134

Contacts and Locations

• Study Contact: Name: Isabelle TALON, MD; Phone Number: 33 3 88 12 72 96; Email: Isabelle.TALON@chru-strasbourg.fr

Study Locations

• France
  • Strasbourg, France, 67091
    • Recruiting
    • Service de Chirurgie Pédiatrique - CHU de Strasbourg - France
    • Principal Investigator: Isabelle TALON, MD
    • Sub-Investigator: François LEFEBVRE, MD
    • Contact: Isabelle TALON, MD; Phone Number: 33 3 88 12 72 96; Email: Isabelle.TALON@chru-strasbourg.fr
    • Sub-Investigator: Soufiane ESSAMOUD, MD
    • Sub-Investigator: Nizar SASSI, MD

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult
• Accepts Healthy Volunteers: N/A

• Sampling Method: Non-Probability Sample

Study Population

Patient (aged between 14-20 years old) having pontaneous pneumothorax without apparent cause and operated on at the HUS between 2010 and 2021.

Description

Inclusion criteria:

• Adult patient (18-20 years old)
• Minor patient aged 14-17 years old
• Any gender
• Spontaneous pneumothorax without apparent cause, between 14 and 20 years old
• Patient operated on at the HUS between 2010 and 2021
• Patient not objecting to the reuse of their data for scientific research purposes.
• Holders of parental authority who do not object to the reuse of their child's data for scientific research purposes.

Exclusion criteria:

• Patient who has expressed his opposition to the reuse of his data for scientific research purposes.
• Holders of parental authority who have expressed their opposition to the reuse of their child's data for scientific research purposes.
• Secondary origin of the pathology: Cystic fibrosis, postoperative pneumothorax, post-traumatic,
• Subject having been treated initially in another structure without further information.

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Retrospective description of the management of spontaneous pneumothorax in adolescents in the Strasbourg University Hospital	This study is retrospective, the analysis focuses on the medical records of patients treated at the Strasbourg University Hospital between between January 1, 2010 and December 31, 2021.	Files analysed retrospectively from January 1, 2010 and December 31, 2021 will be examined

Collaborators and Investigators

• Sponsor: University Hospital, Strasbourg, France

Study record dates

Study Major Dates

• Study Start (Actual): September 1, 2022
• Primary Completion (Estimated): December 1, 2023
• Study Completion (Estimated): December 1, 2023

Study Registration Dates

• First Submitted: September 13, 2022
• First Submitted That Met QC Criteria: December 15, 2023
• First Posted (Estimated): December 18, 2023

Study Record Updates

• Last Update Posted (Estimated): December 18, 2023
• Last Update Submitted That Met QC Criteria: December 15, 2023
• Last Verified: December 1, 2023

More Information

Terms related to this study

• Keywords: Pneumothorax; Spontaneous; Pleural cavity
• Additional Relevant MeSH Terms: Respiratory Tract Diseases; Pleural Diseases; Pneumothorax
• Other Study ID Numbers: 8700

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No